 |
Previous Article | Next Article 
Volume 16, Number 21,
Issue of November 1, 1996
pp. 7010-7020
Copyright ©1996 Society for Neuroscience
Modulation of Forebrain Electroencephalographic Activity in
Halothane-Anesthetized Rat via Actions of Noradrenergic -Receptors
within the Medial Septal Region
Craig W. Berridge1,
Sarah J. Bolen2,
Michael S. Manley2, and
Stephen L. Foote2
1 Psychology Department, University of Wisconsin,
Madison, Wisconsin 53706-1611, and 2 Psychiatry Department,
University of California, San Diego, La Jolla, California 92093
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The locus coeruleus (LC)-noradrenergic system
modulates forebrain electroencephalographic (EEG) activity in
halothane-anesthetized rat. For example, unilateral enhancement of LC
neuronal activity increases cortical EEG (ECoG) and hippocampal EEG
(HEEG) indices of arousal bilaterally (Berridge and Foote, 1991 ).
Conversely, bilateral suppression of LC discharge activity increases
EEG measures of sedation (Berridge et al., 1993b ). The EEG-activating
effects of LC stimulation appear to involve noradrenergic -receptors
(Berridge and Foote, 1991 ).
Two candidate sites at which LC efferents could influence ECoG and HEEG
are the medial septum/vertical limb of the diagonal band of Broca (MS)
and the substantia innominata/nucleus basalis of Meynert (SI). To
determine whether norepinephrine mediates such actions within either of
these regions, the EEG effects of small infusions of a -agonist or
antagonist into MS or SI were examined in halothane-anesthetized rat.
Unilateral infusions (150 nl) of the -agonist isoproterenol (ISO)
(3.75 µg, 17 nmol) into MS, but not SI (150-450 nl), elicited robust
bilateral activation of ECoG and HEEG. Infusions of glutamate (0.5 µg, 3.0 nmol) into either MS or SI elicited bilateral ECoG and HEEG
activation. Neither vehicle infusions into MS nor infusions of ISO into
regions adjacent to MS altered forebrain EEG activity. Bilateral, but
not unilateral, MS infusions of the -antagonist timolol (3.75 µg,
8.7 nmol) decreased EEG indices of arousal in the lightly anesthetized
preparation. Power spectral analyses provided quantitative confirmation
of these qualitative observations.
These results indicate that under these experimental conditions,
noradrenergic efferents, presumably arising from LC, modulate forebrain
EEG state via actions at -receptors located within MS. The results
presented in the accompanying report extend these observations to the
unanesthetized preparation and incorporate additional measures of
behavioral state.
Key words:
norepinephrine;
medial septum;
arousal;
EEG;
-receptors;
locus coeruleus;
waking;
basal forebrain
INTRODUCTION
Distinct amplitude and frequency patterns in
forebrain electroencephalographic (EEG) activity constitute major
defining characteristics of behavioral states (Timo-Iaria et al., 1970 ;
Buzsaki et al., 1988 ; Steriade and McCarley, 1990 ; Steriade and
Buzsaki, 1990 ). During non-rapid eye movement (non-REM) sleep, cortical
EEG (ECoG) exhibits predominant large-amplitude, slow-wave activity
(<1 Hz), whereas hippocampal EEG (HEEG) is characterized by the
presence of mixed-frequency activity. EEG activation, characterized by
low-amplitude, high-frequency fluctuations (desynchronized activity) in
ECoG and theta activity in HEEG, occurs during most periods of alert
waking and REM sleep (Vanderwolf and Robinson, 1981 ). EEG
activation appears to reflect a state of readiness of cortical neurons
for reception of information and rapid response to received information
(Steriade and Buzsaki, 1990 ).
One system posited to participate in the modulation of behavioral state
and state-dependent processes is the noradrenergic nucleus locus
coeruleus (LC) and its efferents (for review, see Foote et al., 1983 ;
Foote and Morrison, 1987 ). Anatomically, this nucleus is well
positioned to affect global brain electrophysiological activity. LC is
a small cluster of norepinephrine (NE)-containing neurons in the
pontine brainstem possessing an extensive efferent projection system
through which it innervates virtually all major regions of the CNS. LC
neurons display state-dependent discharge rates, such that they are
more active in waking than in sleep (Hobson et al., 1975 ; Foote et al.,
1980 ; Aston-Jones and Bloom, 1981a ; Hobson et al., 1986 ). Within
waking, changes in LC neuronal discharge rates precede changes in
behavioral and EEG measures of arousal (Foote et al., 1980 ; Aston-Jones
and Bloom, 1981b ). These and other observations suggest that the
LC-noradrenergic system participates in the induction of changes in
behavioral state and/or state-dependent processes (see Aston Jones et
al., 1991).
In previous studies in halothane-anesthetized rats, microelectrode
recordings were used to guide placement of small (35-150 nl) peri-LC
infusions of drugs and verify that they altered LC discharge levels.
This approach avoids many of the problems associated with techniques
available previously for manipulation of the LC-noradrenergic system
such as lesions, electrical stimulation, and local infusions guided
solely by stereotaxic coordinates (see Berridge and Foote, 1991 ;
Berridge et al., 1993b ). It was observed that selective and reversible
unilateral activation of LC neurons results in bilateral activation of
ECoG and HEEG. These EEG responses are blocked by
intracerebroventricular (ICV) pretreatment with the -receptor
antagonist propranolol (Berridge and Foote, 1991 ). Bilateral, but not
unilateral, suppression of LC activity increased EEG measures of
sedation (Berridge et al., 1993b ). Additional studies demonstrated that
enhanced LC discharge activity is a critical component of the
mechanisms by which hypotensive stress elicits forebrain EEG activation
in the halothane-anesthetized rat (Page et al., 1993 ). These results
indicate that, at least in the halothane-anesthetized preparation, the
LC-noradrenergic system is a potent modulator of forebrain EEG state
through actions of NE at noradrenergic -receptors.
The site(s) at which LC efferents act to modulate EEG state remains to
be elucidated. Among the candidate sites are portions of the basal
forebrain containing the medial septum/vertical limb of the diagonal
band of Broca (collectively referred to as MS) and the substantia
innominata/nucleus basalis of Meynert (SI). MS and SI receive a dense
noradrenergic innervation (Segal, 1976 ; Gaspar et al., 1985 ; Vertes,
1988 ; Chang, 1989 ), the preponderance of which arises from LC (Zaborsky
et al., 1991). Further, both send efferent projections widely
throughout the hippocampal formation and neocortex, respectively
(Meibach and Siegel, 1977 ; Swanson and Cowan, 1979 ; McKinney et al.,
1983 ), and influence HEEG and ECoG (Belardetti et al., 1977 ; Detari and
Vanderwolf, 1987 ; Buzsaki et al., 1988 ; Smythe et al., 1991 ; Metherate
et al., 1992 ). The present studies tested the hypothesis that
noradrenergic projections modulate ECoG and HEEG state in
halothane-anesthetized rats through actions at -receptors located
within MS and SI. In these studies, the EEG effects of small infusions
of a -adrenergic agonist, a -antagonist, and glutamate into sites
within and adjacent to MS and SI were examined. A portion of these
results were reported in preliminary form (Berridge et al., 1993a ).
MATERIALS AND METHODS
Animals and surgery. Male Sprague Dawley rats
(Charles River, Wilmington, MA), weighing 280-350 gm, were
anesthetized with halothane using a face mask. A tracheotomy was then
performed, and halothane (0.75-1.25% in air) was administered via
this route for the duration of the experiment. The animal was placed in
a stereotaxic instrument with the incisor bar set 11.5 mm below ear bar
zero. Body temperature was maintained at 36-38°C.
Drugs/intratissue infusions. In the majority of cases, 26 gauge guide cannulae were then positioned over areas of interest and
cemented into place with dental acrylic. MS cannulae were inserted at
an angle of 4° from vertical (within the coronal plane) to minimize
infusion-induced damage to fibers of passage that travel along the
medial aspect of MS. In some cases (e.g., mapping studies), a cannula
was cemented to a plastic holder held in a micromanipulator. This
facilitated making infusions into multiple sites within a given
subject. Infusions were made via a 33 gauge needle that was inserted
into the cannula and extended 3 mm beyond its ventral tip. This needle
was slightly beveled to minimize travel of fluid up the length of the
needle. The infusion needle was attached to PE20 tubing via a 26 gauge
stainless steel sleeve glued to the needle. The other end of the tubing
was attached to a 10 µl syringe, the plunger of which was advanced
using a microprocessor-controlled infusion pump (Harvard Apparatus,
South Natick, MA). Infusions consisted of 150 nl given over a 60 sec
period. If no effect of drug or vehicle was observed within 10 min of
the first infusion, a second infusion was given. This strategy was
based on previous studies using peri-LC infusions to alter LC neuronal
discharge activity (Berridge and Foote, 1991 ; Berridge et al., 1993b ).
It was observed that under similar conditions, the first infusion was
often less effective than subsequent infusions, presumably because of
dilution of drug within the needle over time. For this reason, when
vehicle infusions were made, two 150 nl infusions were performed,
separated by 10 min. Isoproterenol (ISO) (hydrochloride, 3.75 µg, 17 nmol), timolol (maleate salt, 3.75 µg, 8.7 nmol), and glutamate (0.4 µg, 3.0 nmol) were dissolved in PBS containing 2% Pontamine Sky Blue
dye on the day of the experiment. All drugs were obtained from Sigma
(St. Louis, MO). Atropine sulfate was dissolved in PBS and injected
into the femoral vein via a catheter (PE10 tubing) inserted before the
beginning of data collection.
EEG recording and analyses. Bipolar surface-to-depth
electrodes were used to record ECoG (anterior, +3.0; lateral, ±1.5)
and HEEG (anterior, 4.8; lateral, ±2.5; ventral 2.8) bilaterally.
EEG signals were amplified, filtered (0.1-50.0 Hz bandpass), and
recorded on a polygraph and on magnetic tape. EEG epochs were selected
from preinfusion, postinfusion, and in some cases, recovery portions of
each experiment for power-spectrum analysis (PSA). Each segment was
digitized at a sampling frequency of 300 Hz and tapered at the ends as
a cosine function. The preinfusion segment was defined as ending
immediately before the start of the infusion. The postinfusion epoch
was selected on the basis of visual inspection as the initial portion
of the greatest change in EEG activity from baseline. The recovery
period was defined as the point at which EEG activity first returned to
preinfusion activity levels. Each segment was subjected to fast Fourier
transform and PSA. The mean absolute power and mean relative power
(percentage of total power) were calculated for the frequency bands
0.3-2.3, 3-6.9, 6.9-13.0, 13.0-20.0, 20.0-30.0, 30.0-40.0, and
40.0-50.0 Hz. These frequency bands were selected on the basis of
visual inspection of EEG patterns as being sensitive to changes induced
by sensory stimulation such as tail pinch (see Berridge and Foote,
1991 ). For experiments involving ISO and glutamate infusions, 1 min EEG
segments were subjected to PSA, whereas for the bilateral timolol
infusion experiments, 5 min epochs were used (see below).
Statistical analyses. For MS ISO infusions, ECoG and HEEG
absolute power and relative power for each frequency bandwidth were
analyzed using a paired t test with Bonferoni correction to
compare pre- and postinfusion segments. A one-way, repeated-measures
ANOVA, followed by the Duncan's multiple-range test, was used to
statistically assess EEG recovery in the subset of MS ISO animals for
which spontaneous recovery data were collected. Repeated-measures,
one-way ANOVA was used to assess EEG effects of bilateral MS vehicle
and timolol infusions.
Histology. After each experiment, the animal was deeply
anesthetized and then perfused with 50 ml of 4% formaldehyde. The
brain was removed and placed in perfusion solution. After a minimum of
24 hr, the brain was frozen and 40 µm sections were cut and collected
through MS and other areas in which infusions were made. The sections
were stained with neutral red dye for subsequent examination of the
infusion sites. The distribution of Pontamine Sky Blue dye was noted in
both freshly sectioned and stained tissue.
Dopamine -hydroxylase (DBH)-immunohistochemistry. Animals
were administered an overdose of sodium pentobarbital (100 mg/kg, i.p.)
then perfused transcardially with 100 ml saline, followed by 250 ml 4%
paraformaldehyde in 0.1 M phosphate buffer (PB). The brain
was then removed, blocked and postfixed for 4-6 hr in 4%
paraformaldehyde in 0.1 M PB, then cryoprotected by
saturation with a 30% sucrose solution in 0.1 M PB for
24-48 hr. Coronal sections (35 µm thick) were cut on a freezing
microtome and either rinsed in PB for immediate use or stored in a
cryoprotectant solution containing 30% glycerol and 30% ethylene
glycol in 0.1 M PB for up to 3 months at 15°C.
Sections were incubated in the following solutions for the indicated
times for immunocytochemical localization of DBH: (1) 0.3% hydrogen
peroxide in 0.1 M PB, 30 min; (2) 1% BSA, 10% normal
horse serum (Sigma) in 0.1 M Tris-buffered saline (TBS)
containing 0.3% Triton X-100, 60 min; (3) mouse anti-DBH (Chemicon
International, Temecula, CA), diluted 1:1500, in TBS containing 2%
normal horse serum, 0.1% BSA, and 0.3% Triton X-100, 24 hr at 4°C
with constant shaking; (4) horse anti-mouse IgG (Vector Labs,
Burlingame, CA) diluted 1:300 in the same diluent as in (3), 60 min;
(5) avidin-biotin-peroxidase complex (ABC Elite, Vector Labs),
diluted 1:200, in TBS-0.1% BSA, 60 min; and (6) substrate solution
containing 0.05% diaminobenzidine tetrahydrochloride (Sigma), 0.0004%
nickel chloride, and 0.0002% hydrogen peroxide in 0.1 M
Tris buffer for four 10 min rinses. All incubations were performed at
room temperature unless otherwise indicated. Three 10 min rinses in the
appropriate buffers were performed between steps. Sections were
dehydrated in ascending concentrations of ethanol, then cleared in
xylenes. For dark-field photomicrography, sections were additionally
incubated in chloroform-ethanol (50:50 v/v) for 30 min before clearing
in xylenes. Tissue sections were coverslipped with DPX (BDH Laboratory
Supplies, Poole, England) then photographed using a Nikon Optiphot
microscope with a 4× objective.
Data selection criteria. Data from a particular animal
were included in the analyses for all cases, and in only those cases in
which EEG electrode placements were accurate, EEG recordings were
electrically adequate, and placement of the infusion needle could be
anatomically verified.
RESULTS
General observations
In previous studies, we observed that LC-induced changes in EEG
state are reliable and robust when observed during a stable, carefully
maintained, and appropriate level of anesthesia (Berridge and Foote,
1991 ; Berridge et al., 1993b ). For example, LC activation increases EEG
indices of arousal only when the level of anesthesia is adjusted such
that noxious stimuli (e.g., tail pinch) are capable of eliciting EEG
activation against a background of synchronized ECoG and non-theta HEEG
(Berridge and Foote, 1991 ). Preliminary studies indicated that MS ISO
infusions altered EEG state only under similar anesthetic conditions.
Therefore, in all the ISO and glutamate experiments described below,
halothane concentration was adjusted such that baseline ECoG was
characterized by the stable presence of slow-wave activity (at least 30 min of uninterrupted slow-wave activity before data collection) and a 2 sec tail pinch applied 2.5 cm from the tip of the tail elicited robust
ECoG desynchronization that persisted 10-120 sec beyond termination of
the pinch. Once data collection was initiated, the concentration of
halothane being administered was not altered. Placement of an infusion
needle into MS and other brain regions often induced short periods
(2-3 min) of spreading depression unilaterally in ECoG and HEEG.
Therefore, in all experiments, either dummy needles were first inserted
into the site of interest early in the procedure or the drug-containing
infusion needle was inserted at least 30 min before making an
infusion.
In preliminary studies (n = 35), various infusion
volumes and concentrations of ISO were used. In these studies, EEG
responses were observed, and spread of dye from the infusion site was
assessed. Dye was readily visible at sectioning of fixed tissue. After
a 150 nl infusion, the spread of dye was limited to a radius of
~600-800 µm from the infusion site. This radius was somewhat
smaller in the medial-lateral direction where the midline and lateral
ventricles appeared to form barriers across which the dye did not
readily penetrate. Thus, dye was usually visible only in the region
between midline and the lateral ventricles and was confined to an area
defined by the most anterior and posterior aspects of MS. Dye rarely
spread as far dorsally as the lateral septum. These observations,
together with the EEG effects of these infusions, suggested that an
infusion volume of ~150 nl was adequate to ensure spread of drug
throughout MS while minimizing its spread beyond this region. Doses
substantially below that used in these studies appeared to elicit less
consistent EEG effects.
Effects of unilateral ISO and glutamate infusions into MS on ECoG
and HEEG
Unilateral infusions of ISO (150 nl) into MS (Fig. 1)
(n = 21) resulted in a shift from slow-wave,
large-amplitude to high-frequency, low-amplitude activity in ECoG and
the appearance of nearly pure theta activity in HEEG (Fig.
2). These EEG responses were observed only when
infusions were placed within a radius of ~500 µm of MS (see Figs.
1, 3). In ~30% of the cases, two infusions (separated
by 10 min) were required to elicit this effect (see Materials and
Methods). The EEG responses were observed bilaterally, within 3-8 min
of termination of the infusion, and persisted for 5-90 min
(median = 16 min), as determined from visual inspection.
Comparable EEG responses were observed with repeated ISO infusions.
Response duration and magnitude appeared to most closely correlate with
the level of anesthesia, assessed by intensity and duration of tail
pinch-induced ECoG desynchronization, rather than with the specific
location of the infusion site within MS. Within the limits of the
temporal resolution of the analyses (~1 sec), HEEG and ECoG responses
were generally observed simultaneously. However, in ~50% of the
experiments, the onset of HEEG responses appeared to occur 1-5 sec
before the onset of the ECoG responses. Glutamate infusions into MS
elicited an activation of both ECoG and HEEG similar to that observed
after ISO infusions (n = 7). However, the latency to
onset of the EEG responses was much shorter after glutamate infusions,
ranging from before termination of the infusion to 30 sec after
termination of the infusion. Comparable EEG responses were observed
after repeated glutamate infusions. In nine experiments, two 150 nl
infusions of vehicle were made before effective infusions of ISO
(n = 5) or glutamate (n = 4) (see
below). In all cases, vehicle infusions had no obvious effects on
either HEEG or ECoG (data not shown).
Fig. 1.
Photomicrograph of a neutral red-stained coronal
section showing the position of an effective ISO MS infusion site from
a typical experiment (large arrow). The infusion needle
was lowered into MS at an angle of 4° from vertical, and a 150 nl
infusion of ISO was made over 1 min. The most ventral extent of the
needle track is shown in this section. The lateral ventricle on the
same side is indicated by a small arrow.
AC, Anterior commissure. Original magnification, 25×.
Scale bar, 1 mm.
[View Larger Version of this Image (151K GIF file)]
Fig. 2.
Raw ECoG and HEEG traces and PSA from pre- and
postinfusion periods of a typical MS ISO experiment. A 40 sec raw EEG
trace taken from the 60 sec interval from which the PSA was computed is
shown above each power spectrum. The most striking
postinfusion changes are the decrease in power of the slowest
frequencies in ECoG and the appearance of theta (3-4 Hz) activity in
HEEG. Shading indicates the theta frequency band
(2.3-6.9 Hz) in the HEEG power spectra.
[View Larger Version of this Image (28K GIF file)]
Fig. 3.
Schematic diagram depicting effective and
ineffective MS (A) and SI (B) ISO
infusion sites. A depicts sites at which 150 nl ISO
infusions made within and around the region of MS were either effective
or ineffective at inducing activation of forebrain EEG.
B indicates sites at which ISO infusions (either 150 or
450 nl) were made into SI. In all cases, SI ISO infusions were
ineffective at eliciting EEG activation. Shaded boxes
indicate sites at which ISO infusions elicited forebrain EEG
activation, whereas solid circles indicate sites at
which they did not. AC, Anterior commissure;
CC, corpus callosum; CP,
caudate-putamen; GP, globus pallidus; I,
internal capsule; LS, lateral septum; LV,
lateral ventricle; MS, medial septum; NA,
nucleus accumbens; SI, substantia innominata. Each level
within A or B is separated by 250 µm,
with the most anterior section on the left (modified
from Swanson, 1992 ).
[View Larger Version of this Image (28K GIF file)]
PSA of the MS ISO-induced changes in EEG
PSA demonstrated statistically significant effects of unilateral
MS ISO infusions on ECoG and HEEG consistent with the above-described
qualitative observations (Fig. 2; Table 1). In ECoG
(n = 20) (in one case, it was not possible to obtain an
electrically adequate ECoG recording), the primary effect was a
significant decrease in absolute and relative power of the lowest
frequency band (0.3-2.3 Hz). There were also significant increases in
the relative power of the 20-30, 30-40, and 40-50 Hz bands. In HEEG
(n = 21), ISO induced a decrease in the absolute and
relative power of the 0.3-2.3 Hz frequency band and increased the
absolute and relative power of the theta-activity frequency band
(2.3-6.8 Hz). There was a tendency for increased absolute and relative
power of the higher-frequency bands. However, this was statistically
significant only for absolute power of the 30.0-40.0 Hz band and
relative power of the 20.0-30.0 Hz band. Because of prolonged
drug-induced responses or additional experimental manipulations,
recovery epochs were analyzed only in a subset of the experiments
(n = 13). Absolute and relative power of recovery EEG
epochs for all frequency bands in both ECoG and HEEG did not
significantly differ from preinfusion values (data not shown).
Table 1.
Effects of MS ISO infusions on EEG: mean absolute and
relative power of postinfusion segments of ECoG and HEEG expressed as
percentage of preinfusion
means
| Frequency |
ECoG
|
HEEG
|
| Absolute |
Relative |
Absolute |
Relative |
|
| 0.3
-2.3 |
53 ± 6** |
76
± 5** |
67 ± 5** |
64 ± 4** |
| 2.3 -6.8 |
82
± 5 |
114 ± 8 |
116 ± 5* |
118 ± 4** |
| 6.8
-13.0 |
79 ± 6 |
107 ± 8 |
95 ± 4 |
105
± 4 |
| 13.0 -20.0 |
78 ± 5 |
108 ± 8 |
96
± 4 |
102 ± 5 |
| 20.0 -30.0 |
87 ± 5 |
119
± 10* |
109 ± 5 |
117 ± 2** |
| 30.0 -40.0 |
88
± 5 |
123 ± 11* |
114 ± 5** |
125 ± 10 |
| 40.0
-50.0 |
91 ± 8 |
132 ± 13** |
104 ± 3 |
117
± 10 |
|
|
Absolute and relative power expressed as percentages of
preinfusion means (±SEM) for ECoG (n = 20) and HEEG
(n = 21) for the specified frequency bands. *p < 0.05, **p < 0.01 significantly different from preinfusion
mean determined by t test with Bonferoni correction
(n = 20).
|
|
Effects of ISO infusions made outside the region of MS on ECoG
and HEEG
To determine whether the MS ISO-induced changes in forebrain EEG
resulted from diffusion and subsequent action of ISO outside of MS, ISO
infusions were made into the following regions: (1) the striatum, at a
similar distance from the lateral ventricle as the MS infusions
(n = 6); (2) the region immediately lateral to the
effective MS infusion sites (n = 6); and (3) the
lateral septum (n = 4) (see Fig. 3). These infusions
were made in a subset of the experiments described above using a
within-subjects design. ISO infusions were made into one or two of the
regions listed above outside of MS before making a final, effective
infusion into MS. This design was chosen to minimize the possibility
that negative effects of control-site injections could arise from
factors other than those directly related to the issue of anatomical
site of action such as level of anesthesia or other physiological
concerns. In all cases, if no effects were observed within 10 min after
an infusion, a second infusion was performed. If no effects were
observed within 15 min after the second infusion, the infusion was
considered to be ineffective.
Infusions into striatum, 200-800 µm lateral to the lateral
ventricle, did not elicit noticeable changes in either ECoG or HEEG.
This indicates that diffusion of ISO into the ventricular system is not
responsible for EEG activation observed after ISO infusions into MS.
For infusions into the nucleus accumbens and lateral septum, only
infusions closest to MS elicited EEG activation (see Fig. 3).
Effects of ISO and glutamate infusions into SI on ECoG
and HEEG
In nine cases, 150 nl (n = 6) or 450 nl
(n = 3) infusions of ISO were made into SI (see Fig.
3). In all cases, these infusions did not noticeably alter baseline
HEEG or ECoG as determined by visual inspection (Fig.
4). The ineffectiveness of SI ISO infusions in altering
EEG state might result from insufficient infusion volume or properties
unique to this experimental preparation that interfere with the normal
EEG modulatory action of SI neurons. To assess this possibility,
infusions of glutamate (150 nl) were made into SI. As in previous
studies (Metherate et al., 1992 ), glutamate infusions elicited robust
bilateral activation of both ECoG and HEEG within 30-90 sec after
initiation of the infusion (Fig. 4). Within the temporal resolution of
the EEG measures, both ECoG and HEEG responses usually appeared to
occur simultaneously. However, in a limited number of cases, SI
infusions appeared to elicit ECoG activation 1-3 sec before HEEG
activation.
Fig. 4.
Effects of ISO and glutamate (Glu)
infusions made into SI on ECoG and HEEG. A, ECoG and
HEEG before and after a 150 nl infusion of glutamate into SI. These
infusions elicited robust activation of both ECoG and HEEG as
demonstrated by the reduction of slow-wave activity in ECoG and the
induction of theta-activity in HEEG. B, ECoG and HEEG
taken from same experiment depicted in A before and
after a 450 nl infusion of ISO.
[View Larger Version of this Image (27K GIF file)]
Effects of bilateral MS infusions of the
-antagonist timolol
To determine the degree to which endogenous NE contributes to the
maintenance of forebrain activation, the effects of bilateral infusions
of the -antagonist timolol into MS on ECoG and HEEG activity were
examined (n = 8). Bilateral rather than unilateral
infusions were examined, because in preliminary studies, unilateral MS
timolol infusions did not elicit obvious changes in either ECoG or
HEEG. This is consistent with our previous observation that under
similar experimental conditions, bilateral suppression of LC neuronal
discharge activity was necessary to elicit changes in forebrain EEG
activity (Berridge et al., 1993b ). In all of these experiments,
halothane was carefully adjusted so that low-voltage, high-frequency
activity in ECoG and theta activity in HEEG were consistently present
but that no overt motor responses were observed to noxious stimulation
such as tail pinch. This lightly anesthetized preparation was chosen
because previous studies had demonstrated minimal effects of bilateral
LC suppression on EEG when large-amplitude, slow-wave activity
predominated (Berridge et al., 1993b ). Often, several adjustments of
the level of anesthesia were necessary to obtain these conditions. In
some of the animals, it was not possible to maintain stable EEG
activation. In these cases, short periods (1-2 min) of
large-amplitude, slow-wave activity would appear intermittently. To
ensure that these fluctuations were accurately represented in the data
analyses, at least 30 min of baseline EEG data was collected before
experimental manipulations were initiated, and long (5 min) EEG
segments were used for PSA analyses. The concentration of halothane was
not altered after initiation of data collection.
Under these conditions, bilateral infusion of timolol (3.75 µg/150 nl
in each hemisphere) consistently resulted in the alteration of both
ECoG and HEEG activity (Fig. 5). This concentration was
chosen on the basis of pilot studies that demonstrated inconsistent EEG
effects at concentrations substantially below this. ECoG changes
consisted of a shift from predominantly desynchronized (high-frequency,
low-amplitude) to large-amplitude, slow-wave activity. In the HEEG,
theta-dominated activity was replaced with mixed-frequency activity.
The onset of these EEG responses occurred within 3-30 min (median = 10 min) after the termination of the infusions. The latency between
the initial and the maximal EEG responses, as estimated from visual
inspection of the EEG trace, ranged from 2 to 10 min. The duration of
these EEG responses ranged from 60 min to >120 min. In four of the
eight experiments, the first obvious signs of recovery were observed
before 120 min. However, in two of these cases, additional
manipulations were then made, precluding the use of these animals in
statistical analyses of EEG recovery epochs. In the remaining four
experiments, recovery was not observed within 120 min after the
infusions.
Fig. 5.
Effects of bilateral MS timolol infusions on ECoG
and HEEG. Representative 40 sec epochs of ECoG and HEEG traces taken
from a 5 min epoch used to compute PSA values in Table 2. Displayed are
data taken before any infusions (Pre-Infusion), 15 min
after bilateral MS vehicle infusions (Post-Vehicle), and
15 min after bilateral timolol infusions (Post-Timolol).
Whereas bilateral vehicle infusions did not noticeably affect either
ECoG or HEEG, bilateral timolol infusions increased the occurrence of
slow-wave, large-amplitude activity in ECoG and substantially decreased
the presence of theta activity in HEEG.
[View Larger Version of this Image (19K GIF file)]
Bilateral vehicle infusions were made in seven of the above experiments
30-45 min before bilateral timolol infusions, following a
within-subjects design. In these experiments, 15-30 min after
bilateral vehicle infusions, the needles were removed and filled with
timolol and reinserted into the cannulae. Fifteen minutes after
insertion of the timolol-containing needles, an infusion was made into
each hemisphere.
In all cases, vehicle infusions did not have consistent obvious effects
on either ECoG or HEEG (see Fig. 5, Table 2). Unilateral
infusion of a comparable dose (10-20 µg) of timolol directly into
the lateral ventricles had no obvious effects on either ECoG or HEEG
(data not shown). In four cases, the infusion needles were not
successfully positioned bilaterally within MS (see Fig.
6). In all of these cases, at least one of the infusion
needles was positioned in the most posterior extent of MS, at the level
of the decussation of the anterior commissure, in close proximity to
portions of the bed nucleus of the stria terminalis. In these four
experiments, no obvious effects on either ECoG or HEEG were observed
(data not shown).
Table 2.
Effects of bilateral MS timolol infusions on EEG: mean
absolute and relative power of ECoG and HEEG expressed as percentage of
prevehicle infusion means
| Frequency |
Absolute
power
|
Relative
power
|
| Vehicle |
Timolol |
Vehicle |
Timolol |
|
| ECoG |
| 0.3 -2.3 |
142 ± 38 |
346
± 70** |
111 ± 13 |
170 ± 12** |
| 2.3 -6.8 |
127
± 21 |
205 ± 33** |
109 ± 5 |
105 ± 5 |
| 6.8 -13.0 |
100 ± 8 |
129 ± 10 |
94 ± 9 |
71
± 5** |
| 13.0 -20.0 |
94 ± 6 |
122 ± 9 |
91
± 9 |
67 ± 6** |
| 20.0 -30.0 |
92 ± 3 |
100
± 4 |
94 ± 12 |
59 ± 7** |
| 30.0 -40.0 |
93
± 4 |
78 ± 11 |
95 ± 13 |
55 ± 7** |
| 40.0 -50.0 |
98 ± 7 |
93 ± 5 |
94 ± 14 |
54
± 6** |
| HEEG |
| 0.3 -2.3 |
117 ± 11 |
138
± 7** |
113 ± 8 |
152 ± 8** |
| 2.3 -6.8 |
100
± 3 |
72 ± 5** |
98 ± 5 |
79 ± 3** |
| 6.8 -13.0 |
109 ± 11 |
98 ± 7 |
104 ± 8 |
106
± 5 |
| 13.0 -20.0 |
101 ± 5 |
102 ± 5 |
98
± 3 |
111 ± 3** |
| 20.0 -30.0 |
103 ± 4 |
99
± 3 |
101 ± 3 |
110 ± 3* |
| 30.0 -40.0 |
100
± 4 |
87 ± 4* |
98 ± 6 |
97 ± 5 |
| 40.0 -50.0 |
100 ± 5 |
81 ± 4** |
100 ± 7 |
92
± 5 |
|
|
Absolute and relative power of the subset of experiments
(n = 7) for which 5 min preinfusion, postvehicle, and
post-timolol EEG epochs were collected. Data are expressed as
percentages of preinfusion means (±SEM) for ECoG and HEEG.
*p < 0.05, **p < 0.01 significantly different
from preinfusion mean. Statistical significance determined using a
one-way ANOVA followed by Duncan's multiple-range test.
|
|
Fig. 6.
Schematic diagram depicting effective and
ineffective bilateral timolol infusion sites. Each symbol
pair represents the left and right infusion sites for an
individual experiment. Infusions placed bilaterally within the general
region of MS increased ECoG and HEEG indices of sedation
(EFFECTIVE). Cases in which either one infusion or both
infusions were placed outside of MS did not alter ECoG/HEEG activity
patterns (INEFFECTIVE). See Figure 3 legend for
abbreviations. Schematic depicts three levels through MS separated by
250 µm (modified from Swanson, 1992 ).
[View Larger Version of this Image (35K GIF file)]
PSA of the bilateral MS timolol-induced changes in EEG
PSA was conducted on a subset of animals (n = 7)
for which 5 min prevehicle, postvehicle, and post-timolol EEG epochs
were collected (see Table 2). EEG segments were taken immediately
before vehicle infusions, 15 min after bilateral vehicle infusions, and
15-30 min after bilateral timolol infusions. Post-timolol epochs
containing maximum EEG responses were selected on the basis of visual
inspection. PSA demonstrated statistically significant effects of
bilateral MS timolol infusions, but not vehicle, on ECoG and HEEG
activity consistent with the qualitative observations described above.
Thus, in ECoG, absolute power of the 0.3-2.3 and 2.3-6.8 Hz frequency
bands was significantly increased. Relative power of the 0.3-2.3 Hz
band was also increased, whereas relative power of the five highest
frequency bands was decreased. In HEEG, absolute power and relative
power were increased in the 0.3-2.3 Hz band and decreased in the
2.3-6.8 Hz (theta) frequency band. Absolute power in the 30.0-40.0
and 40.0-50.0 Hz frequency bands was decreased. A small, statistically
significant increase in relative power of the 13.0-20.0 and 20.0-30.0
Hz frequency bands was also observed.
DBH immunoreactivity in MS
The distribution of noradrenergic fibers in the MS region was
examined using immunohistochemical staining for DBH. At the
anterior-posterior level at which the largest number of successful
infusions were made, the highest concentration of DBH-like
immunoreactive (DBH-LI) fibers was contained within the general region
of MS (see Fig. 7). Within this area, DBH-LI was
contained within moderately long, vertically or diagonally oriented
fibers intermingled with shorter, randomly oriented, highly varicose
terminal branches. Some vertically oriented thick fibers that ran
parallel to the midline exhibited large round varicosities and
occasional large terminal boutons. Laterally, toward the edge of the
medial septum-diagonal band complex and just beyond, a rich network of
highly varicose DBH fibers was observed. At the level shown in Figure
7, a low to moderate density of fibers was seen in the region between
the lateral edge of the medial septum and the nucleus accumbens core,
probably contained within the shell of the nucleus accumbens. The
density of these fibers rapidly diminished anteriorally.
Fig. 7.
Dark-field photomicrograph of a coronal section
through MS prepared for immunocytochemical localization of DBH. Note
the high density of DBH-positive fibers in the vicinity of the medial
septum-diagonal band area compared with the much lower density of
fibers laterally (compare with Fig. 1 showing a typical infusion site).
M, midline. Original magnification, 40×. Scale
bar, 0.5 mm.
[View Larger Version of this Image (128K GIF file)]
At slightly more rostral levels (~0.5 mm rostral to Fig. 7), DBH-LI
fibers were even more clearly concentrated within the boundaries of the
medial septum and vertical limb of the diagonal band of Broca. The
majority of DBH-positive fibers were vertically or diagonally oriented
and exhibited occasional round or fusiform varicosities. Intermixed
with these were a few highly varicose fibers with no obvious preferred
orientation. Moving laterally toward the anterior commissure, only a
few DBH-LI fibers were observed. In the anterior nucleus accumbens and
the striatum, only rare DBH-LI fibers of passage were observed (data
not shown). In more caudal sections, (~0.6 mm caudal to Fig. 7)
DBH-LI fibers were more widely distributed. MS exhibited many fine
varicose DBH fibers with nearly random orientation, but the density of
DBH-LI increased dramatically in the vicinity of the anterior
commissure and the bed nucleus of the stria terminalis (data not
shown).
EEG effects of atropine
In four experiments, the effects of the cholinergic antagonist
atropine (50 mg/kg, i.v.) on MS ISO- and MS glutamate-induced ECoG and
HEEG activation were examined. After intravenous saline infusions, ISO
and glutamate infusions into MS elicited robust EEG activation. Ten
minutes after intravenous atropine administration, neither ISO nor
glutamate elicited EEG activation (data not shown). Atropine also
blocked tail pinch-induced EEG activation. Thus, as described for
urethane-anesthetized rats (Vanderwolf and Robinson, 1981 ; Buzsaki et
al., 1983 ), blockade of cholinergic receptors blocks/attenuates EEG
activation observed in response to a variety of manipulations in the
halothane-anesthetized rat.
DISCUSSION
These results indicate that a region of the basal forebrain,
situated either within or immediately lateral to MS, is a site at which
NE acts to modulate forebrain EEG in the halothane-anesthetized rat
through actions at -receptors. Thus, 150 nl infusions of the
-agonist ISO into this region elicited robust, bilateral activation
of HEEG/ECoG. Conversely, bilateral, but not unilateral, infusions of
the -antagonist timolol into this region decreased forebrain EEG
indices of arousal in the lightly anesthetized preparation. Glutamate
infusions into MS also elicited ECoG/HEEG activation, with a response
latency shorter than that observed with ISO. Differences in response
latency after ISO and glutamate could stem from differences in receptor
mechanisms (ionotropic vs metabotropic), pharmacokinetic properties of
these drugs, or differences in circuitry associated with glutamate- and
-receptor-bearing cells. As is the case for the EEG effects produced
by manipulation of LC neuronal activity, the -receptor-mediated EEG
responses occurred only with rigorous control of the level of
anesthesia. ISO-induced EEG activation occurred only when anesthesia
was adjusted to permit tail pinch-induced EEG activation, whereas the
-antagonist increased EEG measures of sedation only when baseline
EEG was in an activated state (lightly anesthetized).
A number of observations suggest that the drug-induced changes in EEG
stem from actions at -receptors. First, neither isoproterenol nor
timolol appears to display substantial affinity for other receptors.
Although certain -antagonists display moderate affinity for
serotonin receptors, the affinity of these drugs for serotonin
receptors is substantially below that for -receptors (Middlemiss,
1986 ). The low dose of both ISO and timolol used in these studies
suggests that the primary action of these drugs was -receptors.
Second, the fact that opposite EEG responses were observed with agonist
and antagonist infusions suggests that the EEG effects result from the
opposing actions of these drugs at -receptors. Finally, in previous
studies, it was observed that both ICV propranolol (Berridge and Foote,
1991 ) and bilateral MS timolol (C. W. Berridge and S. L. Foote,
unpublished observations) blocked/attenuated EEG activation induced by
LC activation, indicating that both treatments prevent
noradrenergic-mediated activation of forebrain EEG.
Site of action
A number of observations indicate that the infusion-induced
changes in ECoG and HEEG stem from action of the infused drugs within
the general region of MS. First, the relatively small infusion volume
(150 nl) imposes a limit on the distance over which physiologically
active drug concentrations will be maintained. Second, ISO infusions
placed outside the immediate vicinity of MS did not alter EEG,
indicating that EEG effects were not attributable to diffusion of drug
into the ventricular system or into the core of the nucleus accumbens
(Zaborsky et al., 1985) (for review, see Deutch et al., 1993 ). Finally,
timolol infusions placed posterior to MS lacked EEG effects. Thus, the
only region examined in which consistent EEG effects were observed
after ISO and timolol infusions was MS and the immediately surrounding
area. This region receives a relatively dense noradrenergic innervation
(Segal, 1976 ; Gaspar et al., 1985 ; Vertes, 1988 ; Chang, 1989 ;
Zaborszky, 1989 ) (see Fig. 7), the vast preponderance of which arise
from LC (Zaborsky et al., 1991).
MS, as defined here, is an anatomically complex area containing neurons
located within the medial septum, the vertical limb of the diagonal
band of Broca, the islands of Calleja, portions of the lateral preoptic
area, and the shell region of the nucleus accumbens. Infusions placed
as far laterally to the shell region of the nucleus accumbens as
effective MS infusions were placed medially did not elicit changes in
EEG state. This suggests that the shell region of the accumbens is not
the site at which -receptors modulate EEG state. However, these
experiments were not designed to differentiate between actions within
the shell of the accumbens and the medial septum. Given that the
posterior portion of the shell of the accumbens lies within close
proximity to the effective infusion sites (Zaborsky, 1985; Deutch et
al., 1993 ) and that it appears to receive a moderate noradrenergic
innervation (C. W. Berridge, T. L. Stratford, S. L. Foote, and A. E. Kelley, unpublished observations), it is currently not possible to
reach a definitive conclusion as to whether infusions did or did not
act within the shell of the nucleus accumbens to influence forebrain
EEG.
Potential circuitry underlying bilateral, simultaneous ECoG, and
HEEG responses
Both SI and MS receive a dense innervation from LC (see above) and
both have been implicated in the regulation of forebrain EEG. SI
influences ECoG (Belardetti et al., 1977 ; Detari and Vanderwolf, 1987 ;
Buzsaki et al., 1988 ; Metherate et al., 1992 ), whereas MS exerts a
strong modulatory influence on HEEG (Buzsaki et al., 1983 ; Smythe et
al., 1991 ). Thus, one plausible hypothesis tested in the present
studies was that LC modulation of ECoG and HEEG is dependent on
NE-induced modulation of SI and MS neuronal activity, respectively.
Infusions of ISO into SI (150-450 nl) did not alter either ECoG or
HEEG. The fact that 150 nl infusions of glutamate into SI elicited
robust activation of ECoG and HEEG indicates the following: (1) the
infusion volumes used in the current study were sufficiently large to
elicit physiologically relevant effects in SI; and (2) modulation of SI
neuronal activity results in modulation of forebrain EEG state in the
halothane-anesthetized rat. The latter observation argues that the lack
of EEG effects of ISO infusions in this region cannot be ascribed to a
unique physiological property of the experimental preparation.
Noradrenergic receptors located within SI other than -receptors
might be involved in noradrenergic-dependent modulation of ECoG.
However, the ability of ICV pretreatment with a -antagonist to block
EEG activation elicited by selective LC activation indicates that
-receptors are critically involved in LC-dependent activation of
ECoG (Berridge and Foote, 1991 ). Combined, these observations suggest
that SI is not a site at which NE exerts a strong modulatory influence
on ECoG activity under these experimental conditions.
Within the limits of temporal resolution (~1-2 sec), near
simultaneous activation of ECoG and HEEG was observed after ISO and
glutamate infusions into MS as well as glutamate infusions into SI. A
number of possible substrates could support the coordinated activation
of cortical and HEEG activity. First, reciprocal projections linking
cortex and hippocampus could provide an anatomical substrate through
which such coordination could be achieved (Van Hoesen et al., 1972 ;
Rosene and Van Hoesen, 1977 ; Swanson, 1981 ). This would be consistent
with the observation that in a limited number of cases, the HEEG
responses preceded ECoG responses by one to many seconds after MS ISO
or glutamate infusions, whereas occasionally ECoG responses were
observed before HEEG responses after SI glutamate infusions. Second,
there exists a prominent septocortical projection, primarily to
cingulate cortex (Saper, 1984 ; Stewart et al., 1985 ; Marston et al.,
1994 ). Thus, alterations in MS neuronal activity could simultaneously
affect cortical and hippocampal activity through direct, monosynaptic
projections. Finally, MS infusions could alter ECoG and HEEG via
efferents to other regions involved in regulation of state such as
hypothalamus, thalamus, or midbrain. Such efferents could be either
direct projections to these regions (Meibach and Siegel, 1977 ; Swanson
and Cowan, 1979 ; Cunningham et al., 1992 ) or indirect via hippocampal
efferents (Swanson and Cowan, 1977 ; Walaas and Fonnum, 1980 ; Ino et
al., 1988 ).
Cholinergic systems
Cholinergic neurons located within MS have been implicated in the
regulation of HEEG theta activity (for review, see Buzsaki et al.,
1983 ). Additional studies have indicated that the ratio of MS GABAergic
to cholinergic neuronal activity may be a critical factor in this
function (Colom et al., 1991 ). NE exerts a primarily inhibitory action
on basal discharge activity of MS neurons (Segal, 1976 ). Consistent
with these findings, we observed in a limited number of cases
(n = 3, data not shown) that MS ISO infusions inhibited
MS neuronal activity, including two neurons that appeared to meet the
criteria for ``theta-on'' cells (Ford et al., 1989 ). Thus, it is
unlikely that the EEG effects observed after ISO infusions into MS
result from the activation of cholinergic neurons. If HEEG theta
activity is dependent on the ratio of the activity between MS GABAergic
and cholinergic neurons, ISO may induce HEEG theta activity through
inhibitory actions on GABAergic neurons.
In urethane-anesthetized rats, systemic administration of the
cholinergic antagonist atropine elicits a profound suppression of EEG
activation (Vanderwolf and Robinson, 1981 ; Buzsaki et al., 1983 ).
Similarly, we observed that in the halothane-anesthetized rat, atropine
blocked HEEG/ECoG activation in response to tail pinch and MS ISO
infusions. This could imply that enhanced cholinergic neurotransmission
mediates the EEG effects observed in this study at a stage subsequent
to the noradrenergic manipulations. However, similar inhibitory effects
on EEG activation are observed after systemic or brainstem
administration of clonidine and other adrenergic
2-agonists, which act to inhibit LC neuronal activity
and NE release (De Sarro et al., 1987 ; Segal et al., 1988 ; Berridge and
Foote, 1991 ; Correa-Sales et al., 1992 ), or after ICV administration of
the noradrenergic -antagonist propranolol in the
halothane-anesthetized rat (Berridge and Foote, 1991 ). Further,
inhibition of serotonergic neurotransmission (Vanderwolf, 1988 ) and
blockade of dopaminergic D2-dopamine receptors (Hartmann,
1978 ; Trampus and Ongini, 1990 ) increases ECoG slow-wave activity.
These observations suggest that normally occurring forebrain EEG
activation is dependent on the simultaneous and concerted action of
multiple ascending systems (Buzsaki et al., 1988 ; Steriade et al.,
1990 ).
Conclusions
Previous studies demonstrated that selective enhancement of LC
discharge rates increases EEG measures of arousal (Berridge and Foote,
1991 ), whereas bilateral suppression of LC activity increases EEG
measures of sedation (Berridge et al., 1993b ). Of direct relevance to
the present report, these EEG-activating effects were
blocked/attenuated with bilateral timolol infusions into MS (C. W. Berridge and S. L. Foote, unpublished observations). Together with the
current observations, these results suggest that in the
halothane-anesthetized rat, LC modulates EEG state via actions of NE at
MS -receptors. Because EEG state fluctuates with behavioral state,
these observations suggest the possibility that LC terminals located
within MS may modulate behavioral state.
The anesthetized preparation offers distinct advantages for
experimentally addressing the question of whether, and at what site,
noradrenergic systems modulate EEG state. This preparation facilitates
the following: (1) electrically adequate EEG recordings; (2) stable
baseline EEG activity; and (3) performance of small infusions in
multiple brain sites using a within-subjects design. However, the use
of the anesthetized preparation substantially limits the degree to
which inferences can be made concerning modulation of behavioral state.
This concern has motivated the studies conducted in the unanesthetized
rat, which are described in the accompanying article (Berridge and
Foote, 1996 ). Combined, these studies provide strong support for the
hypothesis that the LC-noradrenergic system acts within the region of
the basal forebrain containing MS to exert a potent modulatory
influence on behavioral state.
FOOTNOTES
Received May 7, 1996; revised Aug. 14, 1996; accepted Aug. 19, 1996.
This work was supported by Public Health Service Grant MH40008 (S.L.F.)
and a grant from the University of Wisconsin Graduate School
(C.W.B.).
Correspondence should be addressed to Dr. Craig W. Berridge, Psychology
Department, University of Wisconsin, 1202 West Johnson Street, Madison,
WI 53706-1611.
REFERENCES
-
Aston-Jones G,
Bloom FE
(1981a)
Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle.
J Neurosci
1:876-886 .
[Abstract]
-
Aston-Jones G,
Bloom FE
(1981b)
Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli.
J Neurosci
1:887-900 .
[Abstract]
-
Aston-Jones G,
Chiang C,
Alexinsky T
(1991)
Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance.
Prog Brain Res
88:501-520 .
[ISI][Medline]
-
Belardetti F,
Borgia R,
Mancia M
(1977)
Proencephalic mechanisms of ECoG desynchronization in cerveau isole cats.
Electroencephalogr Clin Neurophysiol
42:213-235 .
[ISI][Medline]
-
Berridge CW,
Foote SL
(1991)
Effects of locus Coeruleus activation on electroencephalographic activity in neocortex and hippocampus.
J Neurosci
11:3135-3145 .
[Abstract]
-
Berridge CW,
Foote SL
(1996)
Enhancement of behavioral and electroencephalographic (EEG) indices of waking following stimulation of noradrenergic
-receptors within the medial septal region of the basal forebrain.
J Neurosci
16:6999-7009 .
[Abstract/Free Full Text]
-
Berridge CW,
Bolen SJ,
Foote SL
(1993a)
Modulation of forebrain EEG by medial septal noradrenergic
-receptors.
Soc Neurosci Abstr
19:1832.
-
Berridge CW,
Page ME,
Valentino RJ,
Foote SL
(1993b)
Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus.
Neuroscience
55:381-393 .
[ISI][Medline]
-
Buzsaki G,
Leung LWS,
Vanderwolf CH
(1983)
Cellular bases of hippocampal EEG in the behaving rat.
Brain Res Rev
6:139-171.
-
Buzsaki G,
Bickford RG,
Ponomareff G,
Thal LJ,
Mandel R,
Gage FH
(1988)
Nucleus Basalis and thalamic control of neocortical activity in the freely moving rat.
J Neurosci
8:4007-4026 .
[Abstract]
-
Chang HT
(1989)
Noradrenergic innervation of the substantia innominata: a light and electron microscopic analysis of dopamine
-hydroxylase immunoreactive elements in the rat.
Exp Neurol
104:101-112 .
[ISI][Medline]
-
Colom LV,
Nassif-Caudarella S,
Dicson CT,
Smythe JW,
Bland BH
(1991)
In vivo intrahippocampal microinfusion of carbachol and bicuculline induces theta-like oscillations in the septally deafferented hippocampus.
Hippocampus
1:381-390 .
[Medline]
-
Correa-Sales C,
Rabin BC,
Maze M
(1992)
A hypnotic response to dexmedetomidine, an
2-agonist, is mediated in the locus coeruleus in rats.
Anesthesiology
76:948-952 .
[ISI][Medline]
-
Cunningham JT,
Nissen R,
Renaud LP
(1992)
Norepinephrine injections in diagonal band of Broca selectively reduce the activity of vasopressin supraoptic neurons in the rat.
Brain Res
610:152-155.
-
De Sarro GB,
Ascioti C,
Froio F,
Libri V,
Nistico G
(1987)
Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha-1- and alpha-2-adrenoceptors affect sleep and arousal mechanisms.
Br J Pharmacol
90:675-685 .
[ISI][Medline]
-
Detari L,
Vanderwolf CH
(1987)
Activity of identified cortically projecting and other basal forebrain neurones during large slow waves and cortical activation in anaesthetized rats.
Brain Res
437:1-8 .
[ISI][Medline]
-
Deutch AY,
Bourdelais AJ,
Zahm DS
(1993)
The nucleus accumbens core and shell: accumbal compartments and their functional attributes.
In: The mesolimbic motor circuit and its role in neuropsychiatric disorders
(Kalivas, PW,
Barnes, CD,
eds)
, p. 45. Boca Raton, FL: CRC.
-
Foote SL,
Morrison JH
(1987)
Extrathalamic modulation of neocortical function.
Annu Rev Neurosci
10:67-95 .
[ISI][Medline]
-
Foote SL,
Aston-Jones G,
Bloom FE
(1980)
Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal.
Proc Natl Acad Sci USA
77:3033-3037 .
[Abstract/Free Full Text]
-
Foote SL,
Bloom FE,
Aston-Jones G
(1983)
The nucleus locus ceruleus: new evidence of anatomical and physiological specificity.
Physiol Rev
63:844-914 .
[Free Full Text]
-
Ford RD,
Colom LV,
Bland BH
(1989)
The classification of medial septum-diagonal band cells as theta-on or theta-off in relation to hippocampal EEG states.
Brain Res
493:269-282 .
[ISI][Medline]
-
Gaspar P,
Berger B,
Alvarez C,
Vigny A,
Henry JP
(1985)
Catecholaminergic Innervation of the septal area in man: immunocytochemical study using TH and DBH antibodies.
J Comp Neurol
241:12-33 .
[ISI][Medline]
-
Hartmann E
(1978)
Effects of psychotropic drugs on sleep: catecholamines and sleep.
In: Psychopharmacology: a generation of progress
(Lipton, MA,
DiMascio, A,
Killam, KF,
eds)
, p. 711. New York: Raven.
-
Hobson JA,
McCarley RW,
Wyzinski PW
(1975)
Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups.
Science
189:55-58 .
-
Hobson JA,
Lydic R,
Baghdoyan HA
(1986)
Evolving concepts of sleep cycle generation: from brain centers to neuronal populations.
Behav Brain Sci
9:371-448.[ISI]
-
Ino T,
Itoh K,
Kamiya H,
Shigemoto R,
Akiguchi I,
Mizuno N
(1988)
Direct projections of non-pyramidal neurons of Ammon's horn to the supramammillary region in the cat.
Brain Res
460:173-177 .
[ISI][Medline]
-
Marston HM,
West HL,
Wilkinson LS,
Everitt BJ,
Robbins TW
(1994)
Effects of excitotoxic lesions of the septum and vertical limb nucleus of the diagonal band of Broca on conditional visual discrimination: relationship between performance and choline acetyltransferase activity in the cingulate cortex.
J Neurosci
14:2009-2019 .
[Abstract]
-
McKinney M,
Coyle JT,
Hedreen JC
(1983)
Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system.
J Comp Neurol
217:103-121 .
[ISI][Medline]
-
Meibach RC,
Siegel A
(1977)
Efferent connections of the septal area in the rat: an analysis utilizing retrograde and anterograde transport methods.
Brain Res
119:1-20 .
[ISI][Medline]
-
Metherate R,
Cox CL,
Ashe JH
(1992)
Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine.
J Neurosci
12:4701-4711 .
[Abstract]
-
Middlemiss DN
(1986)
Blockade of the central 5-HT autoreceptor by
-adrenoceptor antagonists.
Eur J Pharmacol
120:51-56 .
[ISI][Medline]
-
Page ME,
Berridge CW,
Foote SL,
Valentino RJ
(1993)
Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress.
Neurosci Lett
164:81-84 .
[ISI][Medline]
-
Rosene DL,
Van Hoesen GW
(1977)
Hippocampal efferents reach widespread areas of cerebral cortex and amygdala in the rhesus monkey.
Science
198:315-317 .
[Abstract/Free Full Text]
-
Saper CB
(1984)
Organization of cerebral cortical afferent systems in the rat. II. Magnocellular basal nucleus.
J Comp Neurol
222:313-342 .
[ISI][Medline]
-
Segal IS,
Vickery RG,
Walton BS,
Dose VA,
Maze M
(1988)
Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha2 adrenergic receptor.
Anesthesiology
69:818-823 .
[ISI][Medline]
-
Segal M
(1976)
Brain stem afferents to the rat medial septum.
J Physiol (Lond)
261:617-631 .
[Abstract/Free Full Text]
-
Smythe JW,
Christie BR,
Colom LV,
Lawson VH,
Bland BH
(1991)
Hippocampal theta field activity and theta-on/theta-off cell discharges are controlled by an ascending hypothalamo-septal pathway.
J Neurosci
11:2241-2248 .
[Abstract]
-
Steriade M,
Buzsaki G
(1990)
Parallel activation of thalamic and cortical neurons by brainstem and basal forebrain cholinergic systems.
In: Brain cholinergic systems
(Steriade, M,
Biesold, D,
eds)
, p. 3. Oxford: Oxford UP.
-
Steriade M, McCarley RW (1990) Brainstem control of
wakefulness and sleep. New York: Plenum.
-
Steriade M,
Datta S,
Pare D,
Oakson G,
Dossi RC
(1990)
Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems.
J Neurosci
10:2541-2559 .
[Abstract]
-
Stewart DJ,
Macfabe DF,
Leung LWS
(1985)
Topographical projection of cholinergic neurons in the basal forebrain to the cingulate cortex in the rat.
Brain Res
358:404-407 .
[ISI][Medline]
-
Swanson LW
(1981)
A direct projection from ammon's horn to prefrontal cortex in the rat.
Brain Res
217:150-154 .
[ISI][Medline]
-
Swanson LW (1992) Brain maps: structure of the rat brain.
Amsterdam: Elsevier.
-
Swanson LW,
Cowan WM
(1977)
An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat.
J Comp Neurol
172:49-84 .
[ISI][Medline]
-
Swanson LW,
Cowan WM
(1979)
The connections of the septal region in the rat.
J Comp Neurol
186:621-656.
[ISI][Medline]
-
Timo-Iaria C,
Negrao N,
Schmidek WR,
Hoshino K,
Lobato de Menezes CE,
Da Rocha TL
(1970)
Phases and states of sleep in the rat.
Physiol Behav
5:1057-1062 .
[Medline]
-
Trampus M,
Ongini E
(1990)
The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat.
Neuropharmacology
29:889-893 .
[ISI][Medline]
-
Vanderwolf CH
(1988)
Cerebral activity and behavior: control by central cholinergic and serotonergic systems.
Int Rev Neurobiol
30:225-341 .
[ISI][Medline]
-
Vanderwolf CH,
Robinson TE
(1981)
Reticulo-cortical activity and behavior: a critique of the arousal theory and a new synthesis.
Behav Brain Sci
4:459-514.
-
Van Hoesen GW,
Pandya DN,
Butters N
(1972)
Cortical afferents to the entorhinal cortex of the rhesus monkey.
Science
175:1471-1473 .
[Abstract/Free Full Text]
-
Vertes RP
(1988)
Brainstem afferents to the basal forebrain in the rat.
Neuroscience
24:907-935 .
[ISI][Medline]
-
Walaas I,
Fonnum F
(1980)
Biochemical evidence for glutamtate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat.
Neuroscience
5:1691-1698 .
[ISI][Medline]
-
Zaborszky L
(1989)
Afferent connections of the forebrain cholinergic projection neurons, with special reference to monaminergic and peptidergic fibers.
In: Central cholinergic synaptic transmission
(Frotscher, M,
Misgel, U,
eds)
, p. 12. Basel: Birkhauser.
-
Zaborszky L,
Alheid GF,
Beinfeld MC,
Eiden LE,
Heimer L,
Palkovits M
(1985)
Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study.
Neuroscience
14:427-453 .
[ISI][Medline]
-
Zaborszky L,
Cullinan WE,
Braun A
(1991)
Afferent to basal forebrain cholinergic projection neurons: an update.
In: The basal forebrain
(Napier, TC,
eds)
, p. 43. New York: Plenum.
This article has been cited by other articles:

|
 |

|
 |
 
J. P. Coles, L. A. Steiner, A. J. Johnston, T. D. Fryer, M. R. Coleman, P. Smieleweski, D. A. Chatfield, F. Aigbirhio, G. B. Williams, S. Boniface, et al.
Does induced hypertension reduce cerebral ischaemia within the traumatized human brain?
Brain,
November 1, 2004;
127(11):
2479 - 2490.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|